Market overview
The global clinic-based rehab therapy robots market is worth USD 632 mn in 2026 and is forecast to reach USD 1.6 bn by 2036, growing at a 9.5% CAGR. United States is the largest country market and Gait and lower-limb systems is the largest by type segment.
| Scope | Robotic therapy systems used in clinics to retrain walking and arm movement after stroke, spinal cord injury and brain injury: gait trainers, upper-limb robots, clinic exoskeletons and balance systems. |
|---|---|
| Industry | Healthcare |
| Value 2025 | USD 580 mn |
| Value 2026 | USD 632 mn |
| Value 2036 | USD 1.6 bn |
| CAGR 2026-2036 | 9.5% |
| Volume 2026 | 4,360 units |
| Volume 2036 | 10,805 units |
| Average price 2026 | USD 145,000 per unit |
| Report price | Starts from USD 1,999 |
| Published | November 2026 |
Request a free sample of this report
Clinic-Based Rehab Therapy Robots market size and forecast, 2026-2036
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Year | Market value |
|---|---|
| 2026 | USD 632 mn |
| 2027 | USD 692 mn |
| 2028 | USD 758 mn |
| 2029 | USD 830 mn |
| 2030 | USD 909 mn |
| 2031 | USD 995 mn |
| 2032 | USD 1.1 bn |
| 2033 | USD 1.2 bn |
| 2034 | USD 1.3 bn |
| 2035 | USD 1.4 bn |
| 2036 | USD 1.6 bn |
Clinic-Based Rehab Therapy Robots market segmentation
By type
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Gait and lower-limb systems | 40.0% | 37.6% | USD 253 mn | 8.8% |
| Upper-limb systems | 34.0% | 35.0% | USD 215 mn | 9.8% |
| Clinic exoskeletons | 16.0% | 18.0% | USD 101 mn | 10.8% |
| Balance and ankle systems | 10.0% | 9.4% | USD 63 mn | 8.8% |
By end user
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Rehabilitation hospitals | 52.0% | 48.4% | USD 329 mn | 8.7% |
| Outpatient clinics | 34.0% | 38.0% | USD 215 mn | 10.7% |
| Universities and research centres | 14.0% | 13.6% | USD 89 mn | 9.2% |
By body region
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Lower limb | 40.0% | 38.0% | USD 253 mn | 8.9% |
| Upper limb | 34.0% | 34.0% | USD 215 mn | 9.5% |
| Hand and finger | 12.0% | 13.0% | USD 76 mn | 10.4% |
| Full-body | 14.0% | 15.0% | USD 89 mn | 10.3% |
By condition
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Stroke | 52.0% | 50.0% | USD 329 mn | 9.1% |
| Spinal cord injury | 18.0% | 18.0% | USD 114 mn | 9.5% |
| Neurological disorders | 18.0% | 19.0% | USD 114 mn | 10.1% |
| Orthopedic | 12.0% | 13.0% | USD 76 mn | 10.4% |
By technology
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Exoskeletons | 40.0% | 40.0% | USD 253 mn | 9.5% |
| End-effector systems | 36.0% | 34.0% | USD 228 mn | 8.9% |
| Virtual reality integrated | 24.0% | 26.0% | USD 152 mn | 10.4% |
Top 25 countries for clinic-based rehab therapy robots by revenue
Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 80.0% of 2026 revenue and the 25 countries below together hold 94.0%.
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| # | Country | Value 2026 | Share 2026 | Value 2036 | CAGR 2026-36 |
|---|---|---|---|---|---|
| 1 | United States | USD 152 mn | 24.0% | USD 373 mn | 9.4% |
| 2 | China | USD 114 mn | 18.0% | USD 335 mn | 11.4% |
| 3 | Japan | USD 57 mn | 9.0% | USD 122 mn | 7.9% |
| 4 | Germany | USD 51 mn | 8.0% | USD 113 mn | 8.3% |
| 5 | South Korea | USD 32 mn | 5.0% | USD 85 mn | 10.3% |
| 6 | France | USD 25 mn | 4.0% | USD 56 mn | 8.3% |
| 7 | Italy | USD 25 mn | 4.0% | USD 55 mn | 8.1% |
| 8 | Switzerland | USD 19 mn | 3.0% | USD 44 mn | 8.8% |
| 9 | United Kingdom | USD 19 mn | 3.0% | USD 44 mn | 8.8% |
| 10 | Spain | USD 13 mn | 2.0% | USD 28 mn | 8.3% |
| 11 | Brazil | USD 11 mn | 1.7% | USD 29 mn | 10.4% |
| 12 | Netherlands | USD 10 mn | 1.6% | USD 24 mn | 9.1% |
| 13 | Canada | USD 9.8 mn | 1.6% | USD 23 mn | 9.1% |
| 14 | Australia | USD 8.7 mn | 1.4% | USD 21 mn | 9.1% |
| 15 | Sweden | USD 7.8 mn | 1.2% | USD 18 mn | 9.1% |
| 16 | Austria | USD 7.0 mn | 1.1% | USD 16 mn | 9.0% |
| 17 | Belgium | USD 6.2 mn | 1.0% | USD 15 mn | 9.0% |
| 18 | Taiwan | USD 5.5 mn | 0.9% | USD 15 mn | 10.3% |
| 19 | Poland | USD 4.9 mn | 0.8% | USD 13 mn | 10.3% |
| 20 | Denmark | USD 4.4 mn | 0.7% | USD 10 mn | 9.0% |
| 21 | India | USD 3.3 mn | 0.5% | USD 8.9 mn | 10.5% |
| 22 | Singapore | USD 2.8 mn | 0.5% | USD 7.7 mn | 10.4% |
| 23 | Mexico | USD 2.7 mn | 0.4% | USD 7.2 mn | 10.2% |
| 24 | Israel | USD 2.3 mn | 0.4% | USD 5.6 mn | 9.2% |
| 25 | Turkey | USD 2.3 mn | 0.4% | USD 6.0 mn | 10.1% |
| Rest of world | USD 38 mn | 6.0% | USD 92 mn | 9.2% |
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
Competitive landscape
Group 1: Global leaders
- Enovis (Hocoma)
- Ekso Bionics
- Fourier Intelligence
- Tyromotion
Group 2: Regional and specialist players
- Bionik Laboratories
- Motorika
- Cyberdyne
- BTS Bioengineering
- Reha Technology
- Gloreha
- AlterG
- Barrett Technology
Group 3: Emerging and niche players
- Neofect
- Motus Nova
- Shenzhen Milebot Robotics
- Siyi Intelligence
- MindMaze
- Harmonic Bionics
Research methodology
Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the clinic-based rehab therapy robots market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.
The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 9.5% is calculated from the resulting values.
The market is divided by type, by end user, by body region, by condition, by technology. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.
Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.
Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.
Frequently asked questions
How big is the clinic-based rehab therapy robots market?
The global clinic-based rehab therapy robots market is estimated at USD 580 mn in 2025 and USD 632 mn in 2026.
How fast will the clinic-based rehab therapy robots market grow?
It is forecast to reach USD 1.6 bn by 2036, a compound annual growth rate of 9.5% from 2026, an increase of USD 935 mn.
Which country is the largest market for clinic-based rehab therapy robots?
United States is the largest market by revenue at USD 152 mn in 2026, 24.0% of the global total. The three largest countries together hold 51.0%.
Which country is growing fastest?
Among the ten largest markets, China is growing fastest at 11.4% a year from 2026 to 2036.
Which clinic-based rehab therapy robots segment is largest?
In the by type split, Gait and lower-limb systems is the largest segment with 40.0% of 2026 revenue.
Who are the leading clinic-based rehab therapy robots companies?
Global leaders include Enovis (Hocoma), Ekso Bionics, Fourier Intelligence, Tyromotion.
Need the full report?
Request a sample to see the structure, tables and country detail.
Request a free sampleRelated markets in Healthcare
- Dystrophic Epidermolysis Bullosa ManagementUSD 632 mn · 8.0% CAGR
- Patient-Matched Orthopedic GuidesUSD 642 mn · 6.8% CAGR
- Transplant Biomarker Risk StratificationUSD 616 mn · 8.5% CAGR
- Hospital-at-Home Vital Signs Monitoring PlatformsUSD 614 mn · 15.0% CAGR
- High-end CellomicsUSD 610 mn · 7.0% CAGR
- Hospital-at-Home Monitoring PlatformsUSD 608 mn · 15.0% CAGR
- Handheld Point-of-Care UltrasoundUSD 660 mn · 9.5% CAGR
- Neuromodulation Closed-Loop Brain-Computer InterfacesUSD 598 mn · 14.0% CAGR